Zilucoplan has been accepted for restricted use in NHS Scotland [...]

A study published in The New England Journal of Medicine [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

Messenger RNA (mRNA) technology could offer a new approach to [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Cartesian Therapeutics has signed a strategic licensing agreement with WestGene [...]

AstraZeneca is presenting a broad package of new clinical and [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

Immunai has signed an agreement worth up to $85 million [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]